总计，前列腺特异性抗原（非复合型及复合型）用于检测前列腺癌
PMA编号：P910007 · 2026-02-23
广告
决定日期2026-02-23
PMA 编号P910007
产品代码MTF
设备分类第3类
医疗专科U
咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。
器械摘要
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Laboratories. It received FDA 510(k) clearance on 2026-02-23. The device is classified under product code MTF. It was reviewed by the IM advisory panel.
常见问题
What is the Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer?
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer is a medical device that received FDA 510(k) clearance on 2026-02-23. The listed applicant is Abbott Laboratories.
When did Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer receive FDA 510(k) clearance?
The clearance date for Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer can be found in the official FDA records.
谁是Total前列腺特异性抗原（非复合物和复合物）用于检测前列腺癌的列名申请人？
FDA 510(k)记录显示，申请人为阿伯特实验室。这本身并不能确立该设备的制造商。
总前列腺特异性抗原（非复合型及复合型）检测前列腺癌的FDA产品代码是什么？
用于检测前列腺癌的Total前列腺特异性抗原（非复合物和复合物）的FDA产品代码是MTF。
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告